Skip to main content

Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease.

Risultati finali

Project website and social media accounts

Project website established allowing public access to non-confidential information about the CARBALIVE project.


Targeting the gut-liver axis in liver disease

Autori: Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S. Bajaj, Rajiv Jalan
Pubblicato in: Journal of Hepatology, Issue 67/5, 2017, Page(s) 1084-1103, ISSN 0168-8278
DOI: 10.1016/j.jhep.2017.05.007

The gut-liver axis in liver disease: Pathophysiological basis for therapy

Autori: Agustín Albillos, Andrea de Gottardi, María Rescigno
Pubblicato in: Journal of Hepatology, 2019, ISSN 0168-8278
DOI: 10.1016/j.jhep.2019.10.003